Woman and Man | Between 18 years et 80 years
- | Country :
- France
- | organs :
- Tête et cou
- | Specialty :
- Immunothérapie - Vaccinothérapie
- Thérapies Ciblées
- Radiothérapie
Extract
GORTEC 2015-01 - A Phase II Randomized Study to Determine the Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With Radiation Therapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck